Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-05-23
2006-05-23
Tate, Christopher R (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
07049285
ABSTRACT:
The present invention relates to new biocompatible polymer derivatives including peptide spacers of formula (I) and their methods of preparation. The present invention also relates to the conjugates formed by covalent or non-covalent bonding and their methods of preparation. These biocompatible polymers with peptide spacers providing regions of hydrophobicity and positive charge can enhance their interaction with cell membrane to increase the cell trafficking, endosomal disruption, the circulation half-life in blood, and the stability of conjugated therapeutic drug.
REFERENCES:
patent: 4179337 (1979-12-01), Davis et al.
patent: 5919455 (1999-07-01), Greenwald et al.
patent: 6042822 (2000-03-01), Gilbert et al.
patent: 6106828 (2000-08-01), Bisgard-Frantzen et al.
patent: 6251866 (2001-06-01), Prakash et al.
patent: 6303752 (2001-10-01), Olsen et al.
patent: 2004/0105839 (2004-06-01), Park
patent: 2004/0192769 (2004-09-01), Greenwald et al.
patent: WO 02/09766 (2002-02-01), None
STN search results. pp. 131-146.
Molineux. Pegylation: Engineering Improved Biopharmaceuticals for Oncology. vol. 23. No. 8 Pt 2, pp. 3S-8S.
Pechar et al. Synthesis of (polyethylene glycol) block copolymers as potential water-soluble drug carriers. Collect Czech Chem Commun 1995. vol. 60, pp. 1765-1780.
http://www.ilpi.com/msds/ref/aliphatic.html, pp. 1-2.
Suzawa, T. et al, “Synthesis and HPLC Analysis of Enzymatically Cleavable Linker Consisting of Poly(ethylene glycol) and Dipeptide for the Development of Immunoconjugate”, J. Control Release, Oct. 3, 2000, 69(1): 27-41, Abstract Only.
Francis Ge et al, “PEGylation of Cytokines and other Therapeutic Proteins and Peptides: The Importance of Biological Optimisation of Coupling Techniques”, Intl J Hematol, Jul. 1998, 68(1):1-18 Abstract Only.
Cordero Garcia Marcela M
Rodman & Rodman
Tate Christopher R
LandOfFree
Biocompatible polymers including peptide spacer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biocompatible polymers including peptide spacer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biocompatible polymers including peptide spacer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3577526